Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients
Paul, Devchand, Vukelja, Svetislava J., Ann Holmes, Frankie, Blum, Joanne L., McIntyre, Kristi J., Lindquist, Deborah L., Osborne, Cynthia R., Sanchez, Ines J., Goldschmidt, Jerome H., Wang, Yunfei, Asmar, Lina, Strauss, Lewis, O’Shaughnessy, Joyce
Published in NPJ breast cancer (28.10.2019)
Published in NPJ breast cancer (28.10.2019)
Get full text
Journal Article
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
JONES, Stephen, HOLMES, Frankie Ann, HYMAN, William J, RICHARDS, Donald A, MENNEL, Robert G, BOEHM, Kristi A, MEYER, Wally G, ASMAR, Lina, MACKEY, Daniel, RIEDEL, Stefan, MUSS, Hyman, SAVIN, Michael A, O'SHAUGHNESSY, Joyce, BLUM, Joanne L, VUKELJA, Svetislava J, MCINTYRE, Kristi J, PIPPEN, John E, BORDELON, James H, KIRBY, Robert L, SANDBACH, John
Published in Journal of clinical oncology (10.03.2009)
Published in Journal of clinical oncology (10.03.2009)
Get full text
Journal Article
A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer
Mahtani, Reshma, Holmes, Frankie-Ann, Badve, Sunil, Caldera, Humberto, Coleman, Robert, Mamounas, Eleftherios, Kalinsky, Kevin, Kittaneh, Muaiad, Lower, Elyse, Pegram, Mark, Press, Michael F., Rugo, Hope S., Schwartzberg, Lee, Vogel, Charles
Published in Clinical breast cancer (01.06.2020)
Published in Clinical breast cancer (01.06.2020)
Get full text
Journal Article
Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer
JONES, Stephen E, SAVIN, Michael A, SANDBACH, John, HYMAN, William J, KHANDELWAL, Pankaj, NEGRON, Angel G, RICHARDS, Donald A, ANTHONY, Stephen P, MENNEL, Robert G, BOEHM, Kristi A, MEYER, Walter G, ASMAR, Lina, HOLMES, Frankie Ann, O'SHAUGHNESSY, Joyce A, BLUM, Joanne L, VUKELJA, Svetislava, MCINTYRE, Kristi J, PIPPEN, John E, BORDELON, James H, KIRBY, Robert
Published in Journal of clinical oncology (01.12.2006)
Published in Journal of clinical oncology (01.12.2006)
Get full text
Journal Article
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2 -amplified early stage breast cancer: a single-group, open-label, phase 2 study
Jones, Stephen E, Dr, Collea, Rufus, MD, Paul, Devchand, DO, Sedlacek, Scot, MD, Favret, Anne M, MD, Gore, Ira, MD, Lindquist, Deborah L, MD, Holmes, Frankie Ann, MD, Allison, Mary Ann K, MD, Brooks, Barry D, MD, Portillo, Raul M, MD, Vukelja, Svetislava J, MD, Steinberg, Michael S, MD, Stokoe, Christopher, MD, Crockett, Maria W, BS, Wang, Yunfei, PhD, Asmar, Lina, PhD, Robert, Nicholas J, MD, O'Shaughnessy, Joyce, MD
Published in The lancet oncology (01.10.2013)
Published in The lancet oncology (01.10.2013)
Get full text
Journal Article
Leptomeningeal metastatic hormone receptor positive, HER2 and PD-L1 negative, breast cancer responds after pembrolizumab added to abemaciclib: A case study
Mahoney, Melissa, Holmes, Frankie Ann, Cho, Benjamin
Published in Current problems in cancer. Case reports (01.12.2020)
Published in Current problems in cancer. Case reports (01.12.2020)
Get full text
Journal Article
Comparison of Menopausal Symptoms During the First Year of Adjuvant Therapy With Either Exemestane or Tamoxifen in Early Breast Cancer: Report of a Tamoxifen Exemestane Adjuvant Multicenter Trial Substudy
JONES, Stephen E, CANTRELL, James, RIVERA, Ragene, HOLMES, Frankie Ann, CHITTOOR, Sreeni, WHITTAKER, Thomas L, BORDELON, James H, KETCHEL, Steven J, DAVIS, Jennifer C, ILEGBODU, Des, KOCHIS, Jean, ASMAR, Lina, VUKELJA, Svetislava, PIPPEN, John, O'SHAUGHNESSY, Joyce, BLUM, Joanne L, BROOKS, Robert, HARTUNG, Nicole L, NEGRON, Angel G, RICHARDS, Donald A
Published in Journal of clinical oncology (20.10.2007)
Published in Journal of clinical oncology (20.10.2007)
Get full text
Journal Article
Abstract PS9-33: Cost-effectiveness of neratinib for the extended adjuvant treatment of adult patients with early-stage, HR+, HER2-overexpressed/amplified breast cancer who initiated neratinib within 1 year of completing trastuzumab in the US
Brodtkorb, Thor-Henrik, McDade, Cheryl, Lalla, Deepa, Holmes, Frankie Ann
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial
Chan, Arlene, Moy, Beverly, Mansi, Janine, Ejlertsen, Bent, Holmes, Frankie Ann, Chia, Stephen, Iwata, Hiroji, Gnant, Michael, Loibl, Sibylle, Barrios, Carlos H., Somali, Isil, Smichkoska, Snezhana, Martinez, Noelia, Alonso, Mirta Garcia, Link, John S., Mayer, Ingrid A., Cold, Søren, Murillo, Serafin Morales, Senecal, Francis, Inoue, Kenichi, Ruiz-Borrego, Manuel, Hui, Rina, Denduluri, Neelima, Patt, Debra, Rugo, Hope S., Johnston, Stephen R.D., Bryce, Richard, Zhang, Bo, Xu, Feng, Wong, Alvin, Martin, Miguel
Published in Clinical breast cancer (01.02.2021)
Published in Clinical breast cancer (01.02.2021)
Get full text
Journal Article
Abstract P2-13-05: Central nervous system metastases as a site of first recurrence in adjuvant therapy trials of HER2+ early breast cancer (EBC)
Lin, Nancy U, Lueftner, Diana, Brufsky, Adam M, Tolaney, Sara M, Melisko, Michelle E, Holmes, Frankie Ann, Awada, Ahmad
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Abstract P2-13-21: Improved central nervous system outcomes in patients with early-stage HER2-positive breast cancer who receive neratinib for the recommended duration: Findings from the phase 3 ExteNET trial
Holmes, Frankie Ann, Patt, Debra, Manalo, Yvonne, Smith, Julie C, Papish, Steven W, Efrat, Noa, Arance, Ana, Zhang, Bo, Lalla, Deepa, Wong, Alvin, Martin, Miguel
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)
Abraham, Jame, Coleman, Robert, Elias, Anthony, Holmes, Frankie Ann, Kalinsky, Kevin, Kittaneh, Muaiad, Lower, Elyse, Mahtani, Reshma, Terry Mamounas, E., Pegram, Mark, Vogel, Charles
Published in Breast cancer research and treatment (01.08.2018)
Published in Breast cancer research and treatment (01.08.2018)
Get full text
Journal Article
Use of cyclin-dependent kinase
Abraham, Jame, Coleman, Robert, Elias, Anthony, Holmes, Frankie Ann, Kalinsky, Kevin, Kittaneh, Muaiad, Lower, Elyse
Published in Breast cancer research and treatment (01.08.2018)
Published in Breast cancer research and treatment (01.08.2018)
Get full text
Journal Article
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine
O'Shaughnessy, Joyce, Koeppen, Hartmut, Xiao, Yuanyuan, Lackner, Mark R, Paul, Devchand, Stokoe, Christopher, Pippen, Jr, John, Krekow, Lea, Holmes, Frankie Ann, Vukelja, Svetislava, Lindquist, Deborah, Sedlacek, Scot, Rivera, Ragene, Brooks, Robert, McIntyre, Kristi, Brownstein, Carrie, Hoersch, Silke, Blum, Joanne L, Jones, Stephen
Published in Clinical cancer research (01.10.2015)
Published in Clinical cancer research (01.10.2015)
Get full text
Journal Article
Abstract PD3-03: Continued efficacy of neratinib in patients with HER2-positive early-stage breast cancer: Final overall survival analysis from the randomized phase 3 ExteNET trial
Holmes, Frankie Ann, Moy, Beverly, Delaloge, Suzette, Chia, Stephen, Ejlertsen, Bent, Mansi, Janine, Iwata, Hiroji, Gnant, Michael, Buyse, Mark, Barrios, Carlos, Silovski, Tajana, Separovic, Robert, Bashford, Anna, Guerrero-Zotano, Angel, Denduluri, Neelima, Patt, Debra, Gokmen, Erhan, Gore, Ira, Smith, John, Bryce, Richard, Xu, Feng, Wong, Alvin, Martin, Miguel, Chan, Arlene
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole
Krekow, Lea K, Hellerstedt, Beth A, Collea, Rufus P, Papish, Steven, Diggikar, Shrinivas M, Resta, Regina, Vukelja, Svetislava J, Holmes, Frankie Ann, Reddy, Praveen K, Asmar, Lina, Wang, Yunfei, Fox, Patricia S, Peck, Susan R, O'Shaughnessy, Joyce
Published in Journal of clinical oncology (10.05.2016)
Published in Journal of clinical oncology (10.05.2016)
Get full text
Journal Article
Scalp Cooling Alopecia Prevention trial (SCALP) for patients with early stage breast cancer
Nangia, Julie R., Wang, Tao, Osborne, Cynthia R. C., Niravath, Polly Ann, Otte, Kristen, Papish, Steven W., Holmes, Frankie Ann, Abraham, Jame, Goldfarb, Shari Beth, Courtright, Jay G., Paxman, Richard, Rude, Mari, Hilsenbeck, Susan G., Osborne, C. Kent, Rimawi, Mothaffar F.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
HER3, PI3K, and JAK2 pathway activation on reverse phase protein microarray (RPMA) in HER2-amplified residual disease (RD) refractory to preoperative chemotherapy plus trastuzumab (H), lapatinib (L), or both (HL)
Holmes, Frankie Ann, Ramos, Corinne, Hoke, Nicholas N, Levin, Maren K., Espina, Virginia A., Liotta, Lance A., Wang, Kai, Palma, Norma Alonzo, O'Shaughnessy, Joyce
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article